SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-264149
Filing Date
2019-10-08
Accepted
2019-10-08 09:15:43
Documents
12
Period of Report
2019-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d814363d8k.htm   iXBRL 8-K 25850
  Complete submission text file 0001193125-19-264149.txt   148256

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20191004.xsd EX-101.SCH 3096
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20191004_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20191004_pre.xml EX-101.PRE 11425
14 EXTRACTED XBRL INSTANCE DOCUMENT d814363d8k_htm.xml XML 3418
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 191141892
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences